Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Exposure of Treatment (n = 41)
| Time Between Operation and Treatment (range) | 40 Days (26–93) |
|---|---|
| Median number of cycles (range) | 8 (2–8) |
| Treatment completion | 34 (82.9%) |
| Discontinuation of treatment | 7 (17.1%) |
| Adverse event | 6 |
| Gastrointestinal disorder | 3 |
| Thrombocytopenia | 2 |
| Death of other diseases | 1 |
| Reccurence | 8 |
| Dose reduction | |
| Oxaliplatin | 20 (48.8%) |
| Capecitabine | 23 (56.1%) |
| Relative dose intensity | |
| Oxaliplatin | 76.5% (17.2–98.8) |
| Capecitabine | 75.8 (55.4–97.2) |
